All In Biotech

Drug Trial Radar · NCT00236054

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril (up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: May 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 440 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

440

Actual

Start

Oct 2004

Primary completion

Not stated

Study completion Dec 2005

Sponsor

Lead sponsor
CephalonIndustry
Sponsor type
Industry
First posted
Oct 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD)

Conditions

  • Generalized Anxiety Disorder

Interventions

  • GabitrilDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to endpoint in the total score of the HAM-A scale.

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Pacific Institute for Medical Research, Inc.

    Los Angeles, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Affiliated Research Institute

    San Diego, California

  • Health Quest Clinical Trials

    San Diego, California

  • Pacific Clinical Research Medical Group

    Upland, California

  • UF Behavioral Health Clinic

    Jacksonville, Florida

  • Janus Center for Psychiatric Research

    West Palm Beach, Florida

  • Atlanta Institute of Medicine & Research - Atlanta Clinic

    Atlanta, Georgia

  • Cunningham Clinical Research, LLC

    Edwardsville, Illinois

  • LSUHSC Anxiety and Mood Disorders Clinic

    New Orleans, Louisiana

  • Summit Research Network

    Farmington Hills, Michigan

  • Social Psychiatry Research Inst.

    Brooklyn, New York

  • Eastside Comprehensive Medical Center

    New York, New York

  • Medical and Behavioral Health Research, PC

    New York, New York

  • Hartford Research Group Ltd.

    Cincinnati, Ohio

  • Oregon Center for Clinical Investigations, Inc.

    Salem, Oregon

  • South East Health Consultants, LLC

    Charleston, South Carolina

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Northbrooke Research

    Brown Deer, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.